These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


409 related items for PubMed ID: 9014991

  • 1. High incidence of appropriate implantable cardioverter-defibrillator therapy in patients with syncope of unknown etiology and inducible ventricular arrhythmias.
    Link MS, Costeas XF, Griffith JL, Colburn CD, Estes NA, Wang PJ.
    J Am Coll Cardiol; 1997 Feb; 29(2):370-5. PubMed ID: 9014991
    [Abstract] [Full Text] [Related]

  • 2. [Patients with structural heart disease, syncope of unknown etiology and inducible ventricular arrhythmias treated with implantable defibrillators].
    Aguinaga L, Mont L, Anguera I, Valentino M, Matas M, Brugada J.
    Rev Esp Cardiol; 1998 Jul; 51(7):566-71. PubMed ID: 9711105
    [Abstract] [Full Text] [Related]

  • 3. Long-term outcome of patients with unexplained syncope treated with an electrophysiologic-guided approach in the implantable cardioverter-defibrillator era.
    Mittal S, Iwai S, Stein KM, Markowitz SM, Slotwiner DJ, Lerman BB.
    J Am Coll Cardiol; 1999 Oct; 34(4):1082-9. PubMed ID: 10520794
    [Abstract] [Full Text] [Related]

  • 4. Implantable defibrillator event rates in patients with unexplained syncope and inducible sustained ventricular tachyarrhythmias: a comparison with patients known to have sustained ventricular tachycardia.
    Andrews NP, Fogel RI, Pelargonio G, Evans JJ, Prystowsky EN.
    J Am Coll Cardiol; 1999 Dec; 34(7):2023-30. PubMed ID: 10588219
    [Abstract] [Full Text] [Related]

  • 5. Low recurrence of syncope in patients with inducible sustained ventricular tachyarrhythmias treated with an implantable cardioverter-defibrillator.
    Garcia-Moran E, Mont L, Cuesta A, Matas M, Brugada J.
    Eur Heart J; 2002 Jun; 23(11):901-7. PubMed ID: 12042012
    [Abstract] [Full Text] [Related]

  • 6. [Arrhythmia recurrence in patients with an old myocardial infarct treated by implantable defibrillator: an analysis according to the initial clinical presentation].
    Vacca M, Mont L, Valentino M, Sambola A, Madariaga R, Matas M, Brugada J.
    Rev Esp Cardiol; 1999 Dec; 52(12):1066-74. PubMed ID: 10659653
    [Abstract] [Full Text] [Related]

  • 7. Implantable cardioverter-defibrillators in hypertrophic cardiomyopathy.
    Vieira AP, Adragão PP, Santos KR, Morgado FB, Cavaco DM, Rossi R, Abecasis M, Neves JP, Bonhosrst D, Gomes JL, Gomes RS.
    Rev Port Cardiol; 2005 Mar; 24(3):407-15. PubMed ID: 15929624
    [Abstract] [Full Text] [Related]

  • 8. Outcome of patients with nonischemic dilated cardiomyopathy and unexplained syncope treated with an implantable defibrillator.
    Knight BP, Goyal R, Pelosi F, Flemming M, Horwood L, Morady F, Strickberger SA.
    J Am Coll Cardiol; 1999 Jun; 33(7):1964-70. PubMed ID: 10362200
    [Abstract] [Full Text] [Related]

  • 9. Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy.
    Meissner MD, Lehmann MH, Steinman RT, Mosteller RD, Akhtar M, Calkins H, Cannom DS, Epstein AE, Fogoros RN, Liem LB.
    J Am Coll Cardiol; 1993 May; 21(6):1406-12. PubMed ID: 8473649
    [Abstract] [Full Text] [Related]

  • 10. Implantable cardioverter-defibrillators in lamin A/C mutation carriers with cardiac conduction disorders.
    Anselme F, Moubarak G, Savouré A, Godin B, Borz B, Drouin-Garraud V, Gay A.
    Heart Rhythm; 2013 Oct; 10(10):1492-8. PubMed ID: 23811080
    [Abstract] [Full Text] [Related]

  • 11. Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter-defibrillators: a case series and a systematic review of the literature.
    Brilakis ES, Friedman PA, Maounis TN, Rokas SG, Shen WK, Stamatelopoulos SF, Cokkinos DV.
    Int J Cardiol; 2005 Feb 28; 98(3):395-401. PubMed ID: 15708170
    [Abstract] [Full Text] [Related]

  • 12. Comparison of event rates and survival in patients with unexplained syncope without documented ventricular tachyarrhythmias versus patients with documented sustained ventricular tachyarrhythmias both treated with implantable cardioverter-defibrillators.
    Pires LA, May LM, Ravi S, Parry JT, Lal VR, Nino CL.
    Am J Cardiol; 2000 Mar 15; 85(6):725-8. PubMed ID: 12000047
    [Abstract] [Full Text] [Related]

  • 13. [Long-term follow-up after implantable loop recorder in patients with syncope: results of a French general hospital survey].
    Salih H, Monsel F, Sergent J, Amara W.
    Ann Cardiol Angeiol (Paris); 2012 Nov 15; 61(5):331-7. PubMed ID: 23062819
    [Abstract] [Full Text] [Related]

  • 14. Implantable cardioverter defibrillator utilization among device recipients presenting exclusively with syncope or near-syncope.
    Militianu A, Salacata A, Seibert K, Kehoe R, Baga JJ, Meissner MD, Pires LA, Schuger CD, Steinman RT, Mosteller RD, Palti AJ, David JB, Lessmeier TJ, Lehmann MH.
    J Cardiovasc Electrophysiol; 1997 Oct 15; 8(10):1087-97. PubMed ID: 9363811
    [Abstract] [Full Text] [Related]

  • 15. Risk stratification for implantable cardioverter defibrillator therapy: the role of the wearable cardioverter-defibrillator.
    Klein HU, Goldenberg I, Moss AJ.
    Eur Heart J; 2013 Aug 15; 34(29):2230-42. PubMed ID: 23729691
    [Abstract] [Full Text] [Related]

  • 16. Unexplained syncope in patients with structural heart disease and no documented ventricular arrhythmias: value of electrophysiologically guided implantable cardioverter defibrillator therapy.
    Pezawas T, Stix G, Kastner J, Wolzt M, Mayer C, Moertl D, Schmidinger H.
    Europace; 2003 Jul 15; 5(3):305-12. PubMed ID: 12842649
    [Abstract] [Full Text] [Related]

  • 17. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
    Bardy GH, Yee R, Jung W.
    J Am Coll Cardiol; 1996 Aug 15; 28(2):400-10. PubMed ID: 8800117
    [Abstract] [Full Text] [Related]

  • 18. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
    Roses-Noguer F, Jarman JW, Clague JR, Till J.
    Heart Rhythm; 2014 Jan 15; 11(1):58-66. PubMed ID: 24120999
    [Abstract] [Full Text] [Related]

  • 19. Residual high incidence of ventricular arrhythmias after left ventricular reconstructive surgery.
    O'Neill JO, Starling RC, Khaykin Y, McCarthy PM, Young JB, Hail M, Albert NM, Smedira N, Chung MK.
    J Thorac Cardiovasc Surg; 2005 Nov 15; 130(5):1250-6. PubMed ID: 16256775
    [Abstract] [Full Text] [Related]

  • 20. Impact of programming strategies aimed at reducing nonessential implantable cardioverter defibrillator therapies on mortality: a systematic review and meta-analysis.
    Tan VH, Wilton SB, Kuriachan V, Sumner GL, Exner DV.
    Circ Arrhythm Electrophysiol; 2014 Feb 15; 7(1):164-70. PubMed ID: 24446023
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 21.